Free Trial
NASDAQ:IMCC

IM Cannabis Q2 2025 Earnings Report

IM Cannabis logo
$2.33 +0.11 (+4.95%)
As of 10:17 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IM Cannabis EPS Results

Actual EPS
-$0.07
Consensus EPS
-$0.14
Beat/Miss
Beat by +$0.07
One Year Ago EPS
N/A

IM Cannabis Revenue Results

Actual Revenue
$9.21 million
Expected Revenue
$12.88 million
Beat/Miss
Missed by -$3.67 million
YoY Revenue Growth
N/A

IM Cannabis Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, August 12, 2025
Conference Call Time
9:00AM ET

Upcoming Earnings

IM Cannabis' Q3 2025 earnings is scheduled for Wednesday, November 12, 2025, with a conference call scheduled on Thursday, November 13, 2025 at 9:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

IM Cannabis Earnings Headlines

New Banking Law #1582 Could Unlock $21 Trillion for Americans
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
See More IM Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IM Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IM Cannabis and other key companies, straight to your email.

About IM Cannabis

IM Cannabis (NASDAQ:IMCC) engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

View IM Cannabis Profile

More Earnings Resources from MarketBeat